$DXC

DXC Technology Co (DXC): Results of Operations and Financial Condition

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DXC Technology Reports First Quarter Fiscal Year 2027 Results • Total revenue for Q1 FY27 of $3.00 billion, down 5.1% YoY, down 6.7% on an organic basis (1) • Q1 FY27 Bookings of $3.0 billion, up 5% YoY with a book to bill ratio of 0.99x • Q1 FY27 EBIT margin of 6.9%

Original reporting
Published Jul 30, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DXC
Neutral
medium confidence
Mentioned
$DXC
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DXCNeutralMed
01

Why it matters

Traders can update models using the provided Q1 performance and the explicit FY27 and Q2 guidance ranges, while separately assessing the contribution of litigation-related cash proceeds to free cash flow.

02

Market read

This is a primary earnings-and-guidance disclosure with specific revenue, EPS, margin, bookings, and free cash flow numbers, plus segment-level booking/profit divergence.

03

What to watch

Bookings dynamics are mixed by segment (GIS bookings up with revenue down; CES bookings down), which can foreshadow future revenue conversion and margin volatility beyond the current quarter.

Relevance 9/10Novelty 8/10Timing: after-hours filing on July 30, 2026, with Q1 FY27 results and full-year guidance ranges
alphai · Earnings readDXC · First Quarter Fiscal Year 2027

DXC Technology Reports First Quarter Fiscal Year 2027 Results

Mixed quarter

Revenue, adjusted EBIT, non-GAAP diluted EPS, and two of three segment revenue lines declined year-over-year, while bookings increased, free cash flow rose with litigation-related proceeds, and full-year guidance was maintained.

Revenue
$3.00 billion
down 5.1% y/y
Consulting and Engineering Services (CES)
$1,231 million
down 1.2% y/y
EPS · non-GAAP
$0.40
down 41.2% y/y
Second Quarter Fiscal Year 2027 and Full Year Fiscal 2027 outlook
Q2 FY27: $2.97 billion to $3.00 billion. FY27: $12.10 billion to $12.35 billion.

Key metrics

as reported
MetricValueq/qy/y
Total revenueGAAP$3.00 billiondown 5.1%
Organic revenue growthnon-GAAPdown 6.7%down 6.7%
EBITnon-GAAP$207 millionup 176.0%
EBIT marginnon-GAAP6.9%
Adjusted EBITnon-GAAP$150 milliondown 30.6%
Adjusted EBIT marginnon-GAAP5.0%
Diluted earnings per shareGAAP$0.73
Non-GAAP diluted earnings per sharenon-GAAP$0.40down 41.2%
Cash generated from operationsGAAP$418 millionup 124.7%
Free cash flownon-GAAP$314 million
Bookingsother$3.0 billionincreased 5%
Book to bill ratioother0.99x
Consulting and Engineering Services segment profitother$100 milliondown 4.8%
Consulting and Engineering Services segment profit marginother8.1%
Consulting and Engineering Services bookingsother0.98xdeclined 18.5%
Global Infrastructure Services segment profitother$38 milliondown 60.8%
Global Infrastructure Services segment profit marginother2.6%
Global Infrastructure Services bookingsother1.11xincreased 34.7%
Insurance segment profitother$34 millionup 3.0%
Insurance segment profit marginother10.7%
Insurance bookingsother0.54xincreased 3.6%

Segments

SegmentRevenueq/qy/y
Consulting and Engineering Services (CES)Revenue was down 3.0% on an organic basis; bookings declined 18.5% year-over-year, with a book to bill ratio of 0.98x.$1,231 milliondown 1.2%
Global Infrastructure Services (GIS)Revenue was down 11.1% on an organic basis; bookings increased 34.7% year-over-year, with a book to bill ratio of 1.11x.$1,449 milliondown 9.4%
Insurance Software & Services (Insurance)Revenue was up 1.4% on an organic basis; bookings increased 3.6% year-over-year, with a book to bill ratio of 0.54x.$319 millionup 1.9%

Second Quarter Fiscal Year 2027 and Full Year Fiscal 2027 outlook

  • RevenueQ2 FY27: $2.97 billion to $3.00 billion. FY27: $12.10 billion to $12.35 billion.
  • Tax rateQ2 FY27: ~44%. FY27: ~40%.
  • NoteQ2 FY27 organic revenue: a decline of 6.5% to 5.5% year-over-year.
  • NoteFY27 organic revenue: a decline of 5.0% to 3.0% year-over-year.
  • NoteQ2 FY27 adjusted EBIT margin: ~6.0%.
  • NoteFY27 adjusted EBIT margin: 6.0% to 7.0%.
  • NoteQ2 FY27 non-GAAP diluted EPS: ~$0.55.
  • NoteFY27 non-GAAP diluted EPS: $2.40 to $2.90.
  • NoteFY27 free cash flow: ~$685 million compared to the prior guide of ~$600 million.
  • NoteQ2 FY27 non-GAAP net interest expense: ~$15.
  • NoteFY27 non-GAAP net interest expense: ~$57.
  • NoteQ2 FY27 foreign exchange impact on revenues: 0.4%.
  • NoteFY27 foreign exchange impact on revenues: 0.6%.
  • NoteQ2 FY27 acquisition & divestitures revenues: —%.
  • NoteFY27 acquisition & divestitures revenues: —%.
  • Note$/Euro exchange rate: $1.16.
  • Note$/GBP exchange rate: $1.34.
  • Note$/AUD exchange rate: $0.71.
  • NoteFY27 non-GAAP net interest expense excludes $46 million of interest income from the full year for the litigation judgment.

Capital returns

  • Returned $70 million of capital to shareholders by repurchasing approximately 6.7 million shares.

What drove it

  • Bookings of $3.0 billion increased 5% year-over-year, with a book to bill ratio of 0.99x.
  • Insurance was the only reported segment with year-over-year revenue growth, up 1.9%.
  • GIS bookings increased 34.7% year-over-year, with a book to bill ratio of 1.11x.
  • The company said it is maintaining its full-year guidance.
  • The FY27 free cash flow increase versus the prior guide reflects litigation related matters.

Concerns

  • Total revenue was down 5.1% year-over-year and down 6.7% on an organic basis.
  • GIS revenue was down 9.4% year-over-year and segment profit was down 60.8% year-over-year.
  • CES bookings declined 18.5% year-over-year.
  • Non-GAAP diluted earnings per share was down 41.2% year-over-year.
  • Reported free cash flow includes cash proceeds of $214 million related to a litigation judgment.

What to watch

  • Execution against Q2 FY27 total revenue guidance of $2.97 billion to $3.00 billion and an organic revenue decline of 6.5% to 5.5% year-over-year.
  • Whether adjusted EBIT margin moves from 5.0% in Q1 FY27 toward Q2 FY27 guidance of ~6.0% and FY27 guidance of 6.0% to 7.0%.
  • Whether GIS converts its 1.11x book to bill ratio into revenue while stabilizing its 2.6% segment profit margin.
  • Whether CES bookings improve from the reported 0.98x book to bill ratio.
  • The composition of FY27 free cash flow of ~$685 million, including the impact of litigation related matters.

Balance sheet and cash flow

  • Cash generated from operations was $418 million, up 124.7% year-over-year.
  • Free cash flow was $314 million, compared to $97 million in the first quarter of fiscal year 2026.
  • Free cash flow in fiscal 2027 includes cash proceeds of $214 million related to a litigation judgment.

Analysis

DXC reported Q1 FY27 total revenue of $3.00 billion, down 5.1% year-over-year and down 6.7% on an organic basis. The reported revenue pattern was uneven across the businesses. CES revenue was down 1.2%, GIS revenue was down 9.4%, and Insurance revenue was up 1.9%. GIS was the largest reported segment by revenue, making its 11.1% organic revenue decline a central issue for the quarter.

Profitability metrics were mixed. EBIT was $207 million, up 176.0% year-over-year, with a 6.9% margin, while adjusted EBIT was $150 million, down 30.6% year-over-year, with a 5.0% margin. Non-GAAP diluted EPS was $0.40, down 41.2% year-over-year, while GAAP diluted earnings per share was $0.73. Segment profit declined 4.8% in CES and 60.8% in GIS, whereas Insurance segment profit increased 3.0%.

Bookings provided a more constructive demand indicator at the consolidated level, increasing 5% year-over-year to $3.0 billion and producing a 0.99x book to bill ratio. GIS bookings increased 34.7% and its book to bill ratio was 1.11x. CES bookings declined 18.5% with a 0.98x book to bill ratio, while Insurance had a 0.54x book to bill ratio despite 3.6% bookings growth.

Cash generation improved sharply, with cash generated from operations of $418 million, up 124.7% year-over-year, and free cash flow of $314 million compared to $97 million in the first quarter of fiscal year 2026. The release states that fiscal 2027 free cash flow includes $214 million of litigation-judgment proceeds, which is important to the quality and composition of reported cash generation. DXC also repurchased $70 million of shares, or approximately 6.7 million shares.

Management maintained its full-year operating outlook. FY27 guidance calls for $12.10 billion to $12.35 billion of revenue, a 5.0% to 3.0% organic revenue decline, a 6.0% to 7.0% adjusted EBIT margin, and $2.40 to $2.90 of non-GAAP diluted EPS. FY27 free cash flow guidance of ~$685 million is above the prior guide of ~$600 million, with the increase attributed to litigation related matters. Q2 FY27 guidance calls for $2.97 billion to $3.00 billion of revenue, a 6.5% to 5.5% organic revenue decline, ~6.0% adjusted EBIT margin, and ~$0.55 of non-GAAP diluted EPS.

Management, verbatim

Our first quarter results were in line with our expectations, and we are maintaining our full-year guidance.

Raul Fernandez, President and CEO

Through our Fast Track approach to innovation, we are bringing a new generation of AI-enabled platforms to market that help customers modernize operations and deliver measurable business outcomes.

Raul Fernandez, President and CEO

Not in the filing

stated, not guessed
  • Period-end date.
  • GAAP gross margin.
  • GAAP operating income.
  • GAAP net income.
  • GAAP operating margin.
  • Prior-year dollar amount for total revenue.
  • Prior-year dollar amounts for EBIT, adjusted EBIT, cash generated from operations, bookings, segment revenue, and segment profit.
  • Prior-quarter comparisons for reported metrics.
  • Cash balance.
  • Debt balance.
  • Dividend information.
  • GAAP diluted EPS prior-year comparison.
  • Q2 FY27 and FY27 gross-margin guidance.
  • Q2 FY27 and FY27 operating-expense guidance.
  • Previous outlook section for formal comparisons of reported results with prior guidance.

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

DXC filed an SEC Form 8-K (Item 2.02) with Exhibit 99.1 covering Q1 fiscal 2027 results and guidance for FY27 and Q2 FY27.

Company-level read

Ticker impact

$DXCNeutralMedium confidence
Context

DXC reported Q1 FY27 results and reiterated full-year guidance, including revenue, EPS, free cash flow, and updated margin outlook.

Expected impact

Near-term repricing risk is moderate, with focus on whether investors discount litigation cash and organic revenue weakness versus maintained guidance.

Evidence & confidence

The filing includes concrete Q1 metrics (revenue down 5.1% YoY, non-GAAP EPS down 41.2% YoY, FCF $314M) plus full-year ranges (revenue $12.10B-$12.35B, adjusted EBIT margin 6.0%-7.0%, non-GAAP EPS $2.40-$2.90). The guidance is maintained, but the quality of FCF is partly litigation-driven, which can create mixed market interpretation.

Market effects

Signals demand and margin pressure in IT services, with GIS weakness offset by Insurance segment profit growth and bookings mix.

Primarily US-listed earnings impact; no explicit regional macro drivers beyond FX assumptions in guidance.

Guidance includes FX assumptions and global enterprise/public sector demand indicators via bookings and segment performance.

Counterpoint

Investors may treat litigation-related cash proceeds as non-recurring and focus on organic revenue decline and adjusted EBIT margin pressure rather than headline free cash flow.

Key entities

  • DXC Technology

    Reported Q1 FY27 results, segment performance, and maintained full-year guidance ranges in an SEC 8-K.

  • Raul Fernandez

    CEO quoted stating results were in line with expectations and full-year guidance is maintained.

  • Paul Taylor

    Incoming President mentioned as strengthening leadership for execution speed and focus.

Every DXC earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.

$DXCMed

IT Services & Consulting Stocks Q2 Results: Benchmarking DXC (NYSE:DXC)

DXC (NYSE:DXC) reported Q2 revenue of $3.00B, down 5.1% YoY, in line with expectations but missing EPS estimates. CEO Fernandez maintained full-year guidance. Gartner (NYSE:IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (NYSE:ACN) reported $18.72B revenue, up 5.6% YoY, with weak guidance. Everforth (NYSE:EFOR) reported $1.01B revenue, down 1.3% YoY, beating estimates. Kyndryl (NYSE:KD) reported $3.62B revenue, down 3.3% YoY, missing estimates. IT services stocks are up 5.

$DXCMedAI 8/10

DXC (DXC) Q1 2027 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Roger Sachs President and Chief Executive Officer - Raul J. Fernandez Chief Financial Officer - Robert F. Del Bene TAKEAWAYS Total Revenue -- $3 billion, representing a 6.7% organic decline year over year. Adjusted EBIT Margin -- 5.0%, a decrease of 180 basis points year over year reflecting the anticipated revenue profile and seasonal factors.

$DXCMedAI 8/10

DXC’s (NYSE:DXC) Q2 CY2026 Earnings Results: Non

IT services provider DXC Technology (NYSE: DXC) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 5.1% year on year to $3.00 billion. On the other hand, next quarter’s revenue guidance of $2.99 billion was less impressive, coming in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.40 per share was 11.3% below analysts’ consensus estimates. Is now the time to buy DXC? Find out by accessing our full research report, it’s free.